Zosano Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Zosano Pharma's estimated annual revenue is currently $7.5M per year.
- Zosano Pharma's estimated revenue per employee is $156,250
- Zosano Pharma's total funding is $242.6M.
Employee Data
- Zosano Pharma has 48 Employees.
- Zosano Pharma grew their employee count by 0% last year.
Zosano Pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Technical Operations | Reveal Email/Phone |
2 | VP, Clinical Development and Medical Affairs | Reveal Email/Phone |
3 | VP, Quality Assurance & Regulatory Affairs | Reveal Email/Phone |
4 | VP & Corporate Contoller | Reveal Email/Phone |
5 | VP Research & Development | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Manager, Process Development | Reveal Email/Phone |
8 | Manager | Reveal Email/Phone |
9 | Senior Manager Equipment Engineering and GMP Facilities | Reveal Email/Phone |
10 | Mfg. Associate III | Reveal Email/Phone |
Zosano Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Zosano Pharma?
Zosano Pharma ™, Inc., formerly named The Macroflux Corporation, is private specialty pharmaceutical company creating better products utilizing innovative drug delivery technology. Zosano’s transdermal microprojection delivery system provides unique benefits including convenient needle-free administration with room temperature stability for various peptides, proteins, small molecules, biopharmaceuticals and vaccines.
keywords:Biotechnology$242.6M
Total Funding
48
Number of Employees
$7.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Zosano Pharma News
Get Zosano Pharma alerts: A number of hedge funds and other institutional investors have recently modified their holdings of ZSAN. Morgan...
FREMONT, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company,...
In pre-market trading, the share price of Zosano Pharma (NASDAQ:ZSAN) stock is incredibly soaring nearly 3,000%. But the total value of all...
Featured companies: BioVex, FullTurn Media, Humanetics, N Spine, Novitas Capital, Reliant Technologies, Symbios, Vaxart, Virtual Radiologic, Winston Laboratories, Zosano Pharma EXPANDING ITEMS: Stay tuned. Vaxart receives $3.3M for oral vaccines — San Francisco’s Vaxart, a biotech developing n ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.6M | 48 | -11% | N/A |
#2 | $10.4M | 48 | 7% | N/A |
#3 | $5.6M | 48 | 41% | N/A |
#4 | $6.9M | 48 | -8% | N/A |
#5 | $12M | 48 | 4% | N/A |